Welcome to CDC Stacks | Cost-related Nonadherence by Medication Type among Medicare Part D Beneficiaries with Diabetes - 42691 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Cost-related Nonadherence by Medication Type among Medicare Part D Beneficiaries with Diabetes
Filetype[PDF - 54.67 KB]


Details:
  • Pubmed ID:
    23032359
  • Pubmed Central ID:
    PMC3780603
  • Funding:
    K08 AG033630/AG/NIA NIH HHS/United States
    U58 DP923530/DP/NCCDPHP CDC HHS/United States
    U58 DP923530-05/DK/NIDDK NIH HHS/United States
    UL1 TR000124/TR/NCATS NIH HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Background

    Despite the rollout of Medicare Part D, cost-related non-adherence (CRN) among older adults remains a problem.

    Objectives

    To examine the rate and correlates of self-reported CRN among a population of older persons with diabetes.

    Research Design

    Cross-sectional.

    Subjects

    1,264 Part D patients with diabetes, who entered the coverage gap in 2006.

    Measures

    Initial administrative medication lists were verified in computer-assisted telephone interviews, in which participants brought their medication bottles to the phone. Medications were classified into cardiometabolic (diabetes, hypertension, cholesterol-lowering), symptom relief, and “other.” Participants were asked if they had any cost-related non-adherence during 2006, and if so to which medication/s. We used the person-medication dyad as the unit of analysis, and tested a multivariate random effects logistic regression model to analyze the correlates of CRN.

    Results

    Approximately 16% of participants reported any CRN. CRN was more frequent for cholesterol-lowering medications [Relative risk 1.54, 95%CI 1.01-2.32] compared to medications taken for symptom relief. CRN was reported less frequently with increasing age above 75 years, compared to patients between 65 and 69. In addition, compared to those with incomes >$40,000, CRN risk for those with incomes <$25,000 was markedly higher [RR 3.05, 95%CI 1.99-4.65].

    Conclusions

    In summary, we found high rates of CRN among Medicare beneficiaries with diabetes, particularly those with lower incomes. We observed more frequent CRN for cholesterol-lowering medications as compared to medications for symptom relief. Efforts to ensure medication affordability for this population will be important in boosting adherence to key medications.